Mimedx Group Inc (MDXG)

R&D Expense Growth

-32.92%

Quarterly · Period ending:

MDXG logo

MDXG R&D Expense Growth

Latest reported-32.92%
MDXG Quarterly R&D Growth (QoQ) (0.00% → -32.92%)
High-resolution chart · PNG

MDXG r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Mimedx Group Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-32.9227%
-13.08%
28.6254%
12.1102%
-0.7512%
-6.8048%
22.3783%
-3.1208%
6.019%
16.7694%
-20.878%
-16.2582%
5.3961%
-35.4815%
-9.2894%
8.0007%
-7.5788%
30.3892%
4.7161%
7.5068%
-6.3609%
26.3541%
1.8387%
49.2696%
-14.7547%
-2.5377%
1.0405%
-4.8444%
-2.55%
-36.0793%
14.5886%
6.534%
4.9083%
2.1614%
-36.6904%
15.4624%
12.97%
21.5856%
18.3967%
-7.8598%
26.9231%
6.6211%
7.0416%
6.4752%
12.1791%
-0.8126%
-8.3416%
11.8888%
29.4964%
0.4034%
7.539%
39.2543%
-25.8502%
9.7788%
35.4134%
66.7091%
23.5865%
-32.9509%
25.1195%
-26.7554%
-21.8676%
44.8694%
-30.565%
11.9857%
31.5%
0%
-100%
22.7227%
-19.1798%
7.9901%
-27.6992%
28.5527%
-99.9867%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.